|Day Low/High||2.71 / 2.89|
|52 Wk Low/High||1.41 / 3.35|
Investors in IntelliPharmaCeutics International Inc saw new options begin trading this week, for the December 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the IPCI options chain for the new December 16th contracts and identified one put and one call contract of particular interest.
Intellipharmaceutics (IPCI) and Mallinckrodt (MNK) have reached a license and commercial supply agreement.
The promotion of Paul Campanelli to CEO indicates a change in the company's focus from acquiring other firms to its roots as a generic pharmaceutical firm.
Catalent and West Pharmaceutical Services provide products and services to biotech and pharmaceutical firms. Intellipharmaceutics is a small-cap firm on the rise.
These under-$10 stocks are making big moves higher. Here's how to trade them from here.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.